By
Drug Target Review2024-07-31T12:00:54
The new study demonstrated that a small molecule inhibitor, BLZ945, could be used as a potential therapeutic to achieve viral clearance.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-06-15T08:00:00Z
2026-06-15T07:00:00Z
Contributor Professor Dipak Ramji, By Drug Target Review
2024-01-26T13:22:42
Sponsored by bit.bio
2023-07-04T10:05:58
Sponsored by Revvity
2023-03-03T14:06:14
Sponsored by Bio-Techne
2025-04-22T14:58:00
Sponsored by Takara Bio USA
2023-03-23T14:46:21
Sponsored by Bio-Techne
2023-04-04T15:03:09
Sponsored by Agilent
Site powered by Webvision Cloud